Teleflex Incorporated (TFX) Plans 2026 Split into Two Independent Companies

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Teleflex Incorporated is one of them.

Teleflex Incorporated (NYSE:TFX) tops our list for being one of the cheap healthcare stocks. It is a global medical technology company and specializes in critical care and surgical devices across hospital and ambulatory settings, including vascular access, interventional urology, respiratory and anesthesia devices, and surgical tools. The company focuses on improving patient outcomes through innovative procedural support.

A major strategic move in 2025 is Teleflex Incorporated (NYSE:TFX)’s planned separation into two independent publicly traded companies. The new entity (“NewCo”) will house the Urology, Acute Care, and OEM businesses, while the remaining company (“RemainCo”) will focus on vascular access, interventional, and surgical segments. This split, expected to be completed in 2026 and structured as tax-free for U.S. shareholders, aims to optimize operational focus, streamline manufacturing, and accelerate growth.

The corporation is also expanding its vascular intervention portfolio through the planned €760 million acquisition of Biotronik’s vascular intervention business, set to close by Q3 2025. This deal is expected to strengthen its interventional care offerings and support revenue growth. The company reported strong Q2 2025 results, with revenues up 4.2% to $780.9 million and EPS of $3.73, alongside a net profit margin of 6.31%, underlining operational strength ahead of the planned split.

Innovation remains a key driver, highlighted by the launch of Barrigel Rectal Spacer in Japan, designed to reduce long-term side effects of radiation therapy for prostate cancer. This reflects Teleflex Incorporated (NYSE:TFX)’s focus on specialized, minimally invasive technologies that enhance patient quality of life.

While we acknowledge the potential of TFX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure. None.